Qigong's Impact on Well-Being and Balance in Multiple Sclerosis Patients
This study aims to evaluate the impact of Qigong on the well-being and balance of individuals with Multiple Sclerosis, using the Multiple Sclerosis Impact Scale-29 (MSIS-29), a patient-reported questionnaire that assesses the physical and psychological effects of the condition.
Conventional rehabilitation therapy
+ Qi gong Baduanjin Exercises
Autoimmune Diseases+4
+ Demyelinating Diseases
+ Immune System Diseases
Treatment Study
Summary
Study start date: December 1, 2025
Actual date on which the first participant was enrolled.This clinical trial focuses on exploring the effects of Qigong, a traditional Chinese practice that combines concentration, visualization, breathing, posture, and movement, on patients diagnosed with Multiple Sclerosis (MS). The goal of Qigong is to enhance and balance life energy (Qi). MS, a neurological disease, often reduces the quality of life of patients due to chronic disability, dependency, and associated psychosocial disorders like anxiety and depression. This study aims to see if Qigong can improve the overall well-being and balance of MS patients, as no previous study has compared Qigong exercises with conventional rehabilitation methods in MS treatment. The study is a randomized controlled clinical trial, involving patients from the Physical Medicine and Rehabilitation outpatient clinic at Başkent University. The minimum required sample size is 148 participants, divided equally into a Qigong group and a control group. The primary outcome of the study will be measured using the Multiple Sclerosis Impact Scale-29 (MSIS-29), a patient-reported questionnaire designed to assess the physical and psychological impact of MS on an individual's daily life. The MSIS-29 provides a comprehensive view of how MS affects a patient's quality of life, with higher scores indicating a greater impact.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.36 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Baskent University Medical faculty
Ankara, Turkey (Türkiye)Open Baskent University Medical faculty in Google Maps